Literature DB >> 27313684

MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1.

Haoning Fan1, Meng Shao1, Shaohui Huang1, Ying Liu2, Jie Liu2, Zhiyuan Wang2, Jianxin Diao1, Yuanliang Liu1, L I Tong1, Qin Fan1.   

Abstract

Curcumin (Cur) exhibits radiosensitization effects to a variety of malignant tumors. The present study investigates the radiosensitizing effect of Cur on nasopharyngeal carcinoma (NPC) cells and whether its mechanism is associated with microRNA-593 (miR-593) and multidrug resistance gene 1 (MDR1). A clonogenic assay was performed to measure the radiosensitizing effect. The expression of miR-593 and MDR1 was analyzed by quantitative polymerase chain reaction (qPCR) or western blot assay. A transplanted tumor model was established to identify the radiosensitizing effect in vivo. A luciferase-based reporter was constructed to evaluate the effect of direct binding of miR-593 to the putative target site on the 3' UTR of MDR1. The clonogenic assay showed that Cur enhanced the radiosensitivity of cells. Cur (100 mg/kg) combined with 4 Gy irradiation inhibited the growth of a transplanted tumor model in vivo, resulting in the higher inhibition ratio compared with the radiotherapy-alone group. These results demonstrated that Cur had a radiosensitizing effect on NPC cells in vivo and in vitro; Cur-mediated upregulation of miR-593 resulted in reduced MDR1 expression, which may promote radiosensitivity of NPC cells.

Entities:  

Keywords:  curcumin; microRNA-593; multidrug resistance gene 1; nasopharyngeal carcinoma; radiosensitization

Year:  2016        PMID: 27313684      PMCID: PMC4888061          DOI: 10.3892/ol.2016.4438

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Identification of microRNAs associated with lymphangiogenesis in human gastric cancer.

Authors:  B Yang; C Jing; J Wang; X Guo; Y Chen; R Xu; L Peng; J Liu; L Li
Journal:  Clin Transl Oncol       Date:  2013-07-24       Impact factor: 3.405

Review 3.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.

Authors:  G Sanguineti; F B Geara; A S Garden; S L Tucker; K K Ang; W H Morrison; L J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-15       Impact factor: 7.038

5.  GRP78 mediates the therapeutic efficacy of curcumin on colon cancer.

Authors:  Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung; Wei-Yu Chen; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-10-04

6.  Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras.

Authors:  Jee-Sun Oh; Jae-Jin Kim; Ju-Yeon Byun; In-Ah Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

7.  MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.

Authors:  G Ke; L Liang; J M Yang; X Huang; D Han; S Huang; Y Zhao; R Zha; X He; X Wu
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

8.  Curcumin enhances the radiosensitivity in nasopharyngeal carcinoma cells involving the reversal of differentially expressed long non-coding RNAs.

Authors:  Qirui Wang; Haoning Fan; Ying Liu; Zhixin Yin; Hongbing Cai; Jie Liu; Zhiyuan Wang; Meng Shao; Xuegang Sun; Jianxin Diao; Yuanliang Liu; Li Tong; Qin Fan
Journal:  Int J Oncol       Date:  2013-12-30       Impact factor: 5.650

9.  DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.

Authors:  Marijn T M van Jaarsveld; Maikel D Wouters; Antonius W M Boersma; Marcel Smid; Wilfred F J van Ijcken; Ron H J Mathijssen; Jan H J Hoeijmakers; John W M Martens; Steven van Laere; Erik A C Wiemer; Joris Pothof
Journal:  Mol Oncol       Date:  2013-12-31       Impact factor: 6.603

10.  MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14).

Authors:  Tian Zhang; Quanquan Sun; Tongxin Liu; Jiarong Chen; Shasha Du; Chen Ren; Guixiang Liao; Yawei Yuan
Journal:  Tumour Biol       Date:  2014-09-09
View more
  8 in total

1.  Human nasopharyngeal carcinoma can be radiosensitized by trichosanthin via inhibition of the PI3K pathway.

Authors:  Wen Wang; Bo Tan; Jingwei Zhang; Rongliang Qiu; Xinju Liu; Dongmei Liu; Xue Li; Jianhua Wang
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

2.  Long noncoding RNA ENST00000413528 sponges microRNA-593-5p to modulate human glioma growth via polo-like kinase 1.

Authors:  Ren Zhang; Ruo-Lun Wei; Wei Du; Li-Wei Zhang; Tao Du; Ya-Dong Geng; Xin-Ting Wei
Journal:  CNS Neurosci Ther       Date:  2019-03-28       Impact factor: 5.243

3.  Curcumin Enhances Radiosensitization of Nasopharyngeal Carcinoma via Mediating Regulation of Tumor Stem-like Cells by a CircRNA Network.

Authors:  Daoqi Zhu; Meng Shao; Jiabin Yang; Miao Fang; Shiya Liu; Dandan Lou; Ruijiao Gao; Ying Liu; Aiwu Li; Ying Lv; Zhixian Mo; Qin Fan
Journal:  J Cancer       Date:  2020-02-10       Impact factor: 4.207

4.  Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE.

Authors:  Wencui Yang; Xiaoning Li; Lin Zhao; Fengju Zhao
Journal:  J Healthc Eng       Date:  2021-09-08       Impact factor: 2.682

Review 5.  Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers.

Authors:  Vasiliki Zoi; Vasiliki Galani; Pericles Tsekeris; Athanasios P Kyritsis; George A Alexiou
Journal:  Biomedicines       Date:  2022-01-28

Review 6.  The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review).

Authors:  Yun Liu; Hongmei Sun; Bolat Makabel; Qingbin Cui; Jiajun Li; Chaoyue Su; Charles R Ashby; Zhesheng Chen; Jianye Zhang
Journal:  Oncol Rep       Date:  2019-05-03       Impact factor: 3.906

7.  miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.

Authors:  Fang Wei; Mofei Wang; Zhen Li; Yong Wang; Yong Zhou
Journal:  Mol Med Rep       Date:  2019-10-29       Impact factor: 2.952

8.  Circ_0061825 Acts as a miR-593-3p Sponge to Promote Breast Cancer Progression by Regulating FGFR3 Expression.

Authors:  Jiping Xie; Yi Wan; Min Zhang; Zeyu Jin; Yongqiang Yao
Journal:  Cancer Manag Res       Date:  2020-11-04       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.